Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations

Autor: Postma, MJ, Bos, JM, Welte, R, Groot, Ronald, Luytjes, W, Rümke, HC, Beutels, P

Publikováno v: European Journal of Health Economics, 5, 1, pp. 54-7
European Journal of Health Economics, 5, 54-7
European Journal of Health Economics (HEPAC), 24, 1-7. Springer

Contains fulltext : 57816.pdf (Publisher’s version ) (Closed access)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cc986cb1e24c101eac492beac5500b74
https://hdl.handle.net/2066/57816

Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: a randomized study of a single dose vs. two different two-dose schedules

Autor: Vesikari, T, Hardt, R, Rümke, Hc, Icardi, Giancarlo, Montero, J, Thomas, S, Sadorge, C, Fiquet, A.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3710::3862e13fb7e06ad7b5e4f799f1d07d58
http://hdl.handle.net/11567/823125

Immunogenicity and safety of monovalent RIVM meningococcal B OMP vesicle F91 vaccine administered to children that received hexavalent meningococcal B vaccine 2,5 years ago

Autor: Lafeber, AB, van Limpt, KCJP, Berbers, GAM, Labadie, J, Kleyn, E, Groot, Ronald, Rümke, HC, van Alphen, AJW

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::a7763b1ff74fcb54f7230b2b589cf11b
https://pure.eur.nl/en/publications/c253cefd-0067-4b21-8a87-6db0d17d498e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.